0001179110-18-001881.txt : 20180209 0001179110-18-001881.hdr.sgml : 20180209 20180209160149 ACCESSION NUMBER: 0001179110-18-001881 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180208 FILED AS OF DATE: 20180209 DATE AS OF CHANGE: 20180209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Milne Jill C. CENTRAL INDEX KEY: 0001644246 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 18591631 MAIL ADDRESS: STREET 1: C/O CATABASIS PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2018-02-08 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001644246 Milne Jill C. C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLDG 1400E, STE B14202 CAMBRIDGE MA 02139 1 1 0 0 CEO and President Stock Option (right to buy) 1.28 2018-02-08 4 A 0 230000 0 A 2028-02-07 Common Stock 230000 230000 D This option was granted on February 8, 2018 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 8, 2018 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. /s/ Jill C. Milne 2018-02-09